Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1

Virology

Volumn 273, Issue 1, 2000, Pages 16-20

  Stitz, J ^a   Buchholz, C J ^a   Engelstadter M ^a   Uckert, W ^b   Bloemer, U ^c   Schmitt, I ^a   Cichutek, K ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

10A1 Env; GaLV Env; Lentiviral vector; Pseudotype vector

Indexed keywords

ENVELOPE PROTEIN; VIRUS RECEPTOR;

ARTICLE; GENE TRANSFER; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN CELL; LENTIVIRINAE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS TYPING;

ALOCASIA MACRORRHIZOS; AMPHOTROPIC MURINE LEUKEMIA VIRUS; ANIMALIA; GIBBON APE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HYLOBATES SP.; LENTIVIRUS; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 0034691558     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0394     Document Type: Article

References (19)

1. von Kalle C., Kiem H. P., Goehle S., Darovsky B., Torok-Strob B., Strob R., Schuening F. G. Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood. 84:1994;2890-2897.
2. + T lymphocytes by MaLV-10A1 retrovirus pseudotype. Hum. Gene Ther. 11:2000;1005-1014.
3. Richardson C., Bank A. Developmental-stage-specific expression and regulation of an amphotropic retroviral receptor in hematopoietic cells. Mol. Cell. Biol. 16:1996;4240-4247.
4. Miller D. G., Miller A. D. A family of retroviruses that utilize related phosphate transporters for cell entry. J. Virol. 68:1994;8270-8276.
5. Uchida N., Sutton R. E., Friera A. M., He D., Reitsman M. J., Chang W. C., Veres G., Scollay R., Weissman I. L. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA. 95:1998;11939-11944.
6. Mochizuki H., Schwartz J. P., Tanaka K., Brady R. O., Reiser J. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J. Virol. 72:1998;8873-8883.
7. Cosset F.-L., Takeuchi Y., Battini J. L., Weiss R. A., Collins M. K. High. titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:1995;7430-7436.
8. Naldini L., Blomer U., Gage F. H., Trono D., Verma I. M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA. 93:1996;11382-11388.
9. Soneoka Y., Cannon P. M., Ramsdale E. E., Griffiths J. C., Romano G., Kingsman S. M., Kingsman A. J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:1995;628-633.
10. Schnierle B. S., Stitz J., Bosch V., Nocken F., Merget-Millitzer H., Engelstadter M., Kurth R., Groner B., Cichutek K. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. USA. 94:1997;8640-8645.
11. Bugelski P. J., Maleeff B. E., Klinker A. M., Ventre J., Hart T. K. Ultrastructural evidence of an interaction between Env and Gag proteins during assembly of HIV type 1. AIDS Res. Hum. Retroviruses. 11:1995;55-64.
12. Sakalian M., Hunter E. Molecular events in the assembly of retrovirus particles. Adv. Exp. Med. Biol. 440:1998;329-339.
13. Wilk T., Pfeiffer T., Bosch V. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology. 189:1992;167-177.
14. Henriksson P., Pfeiffer T., Zentgraf H., Alke A., Bosch V. Incorporation of wild. type and C-terminally truncated human epidermal growth factor receptor into human immunodeficiency virus-like particles: Insight into the processes governing glycoprotein incorporation into retroviral particles. J. Virol. 73:1999;9294-9302.
15. Rein A., Mirro J., Haynes J. G., Ernst S. M., Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68:1994;1773-1781.
16. Kiernan R. E., Freed E. O. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: Transdominant inhibition by matrix mutations. J. Virol. 72:1998;9621-9627.
17. Miller A. D., Garcia J. V., von Suhr N., Lynch C. M., Wilson C., Eidem M. V. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:1991;2220-2224.
18. Ott D., Friedrich R., Rein A. Sequence analysis of amphotropic and 10A1 murine leukemia viruses: Close relationship to mink cell focus-inducing viruses. J. Virol. 64:1990;757-766.
19. Stitz J., Steidl S., Merget-Millitzer H., Konig R., Muller P., Nocken F., Engelstadter M., Bobkova M., Schmitt I., Kurth R., Buchholz C. J., Cichutek K. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients. Virology. 267:2000;229-236.